Quick Answer
ARTELO BIOSCIENCES, INC. reported Diluted EPS of $12.52 per share (loss) for fiscal year 2025.
ARTELO BIOSCIENCES, INC. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$12.52 | +31.6% |
| 2024 | -$18.30 | -482.8% |
| 2023 | -$3.14 | -115.1% |
| 2019 | -$1.46 | +20.7% |
| 2018 | -$1.84 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$3.97 | -89.0% | +29.2% |
| June 30, 2025 | -$5.61 | -24.1% | -679.2% |
| March 31, 2025 | -$0.72 | +7.7% | +65.7% |
| September 30, 2024 | -$2.10 | -153.0% | +53.5% |
| June 30, 2024 | -$4.52 | — | -479.5% |
| March 31, 2024 | -$0.78 | — | +6.0% |
| September 30, 2023 | -$0.83 | — | -107.5% |
| February 29, 2020 | -$0.40 | +0.0% | +0.0% |
- ARTELO BIOSCIENCES, INC. showed an increase of +31.6% in Diluted EPS compared to the prior fiscal year.
- Over the 2018–2025 period, ARTELO BIOSCIENCES, INC.’s diluted eps has declined by 580.4% (from $1.84 per share (loss) to $12.52 per share (loss)).
- The most recent figure is from ARTELO BIOSCIENCES, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: